CLINICAL EVALUATION OF SIDDHA MEDICINE MURUNGAI NEI FOR AAN MALADU (MALE INFERTILITY DUE TO OLIGOSPERMIA)
Phase 2
- Conditions
- Health Condition 1: N461- Oligospermia
- Registration Number
- CTRI/2022/11/047534
- Lead Sponsor
- Dr Anu A
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Marital status-more than 1 year.
2.Oligospermia (Sperm count <15 million per ejaculation.)
3.Asthenozoospermia (Motility less than 40%)
4.Oligoasthenozoospermia.
Exclusion Criteria
1.Azoospermia.
2.Teratospermia.
3.Oligo-astheno-teratozoospermia
4.Erectile Dysfunction.
5.Hydrocele.
6.Varicocele.
7.Diabetes Mellitus.
8.Hypertension.
9.Cardia Diseases.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Increased sperm count and increased motility function is assessed by semen analysis. <br/ ><br>Any one or more among the above in a period of 48 days or more during the study will be considered as primary outcome.Timepoint: Increased sperm count and increased motility function is assessed by semen analysis. <br/ ><br>Any one or more among the above in a period of 48 days or more during the study will be considered as primary outcome.
- Secondary Outcome Measures
Name Time Method Safety and Efficacy of the drug will be assessed during the course of the study.Timepoint: Safety and Efficacy will be assessed in a time period of 48 days.